Novelty in Biomedicine. 2017; 5 (4): 172-176
in En
| IMEMR
| ID: emr-189668
Responsible library:
EMRO
Search on Google
Index:
IMEMR
Main subject:
Ribavirin
/
Cross-Sectional Studies
/
Prospective Studies
/
Risk Factors
/
Interferon-alpha
/
Drug Therapy, Combination
Type of study:
Prevalence_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Novelty Biomed.
Year:
2017